Since our publication of Cost of Higher for Longer in February, we have seen interest rates across the curve move higher with expectation for rates to remain restrictive for longer. Liquidity continues to contract as G5 Central Banks shrink balance sheets at an unprecedented pace (~$5.5T over the last six quarters, see Figure 12MSCI ACWI Co-moves with Big-5 CB Assets…
The Cost of Even Higher for Longer and Tightening Liquidity
A financial market resource for the every-day investor and trader.
-
J.P. Morgan: Resilience or Complacency
Seth Golden, , Research Reports, 0
Good Sunday to all of our Finom Group members. Due to this week’s engagement at The Money Show in...
-
Can Q1 Earnings Vault The S&P 500 Over Geopolitical Concerns
Seth Golden, , Research Reports, 0
Closing out the 1st week of earnings season found the major averages higher last week. In the wake of...
-
Fundstrat: S&P 500 into 2H
Seth Golden, , Research Reports, 0
S&P 500 and QQQ both showed minor weakness late this week, yet failed to do much technical damage. Both...
-
Weekly State Of The Market: Weak/Bad Breadth
Seth Golden, , Research Reports, 0
“It’s one thing to have forecasts, but if you can’t get what’s going on right now correct, there’s no...
-
Macy’s Situation Is Getting Worse, As Previously Forecast: No Solution In Sight
Seth Golden, , Research Reports, 0
The situation at Macy’s (M) is as bad as it was when I began covering the company in January...
-
Morgan Stanley: It’s Not A Bubble, It’s Not
Seth Golden, , Research Reports, 0
Correction has arrived, positioning and leverage should do the rest. A combination of peaking rate of change in M1/M2and...
-
Debt Ceiling Lay Ahead: Are There Reasons To Be Bullish?
Seth Golden, , Research Reports, 0
There are a great many opinions on the market and the potential outcome/s for the debt ceiling that lay...
-
Artisan Parnters: Investing in Health Care: Beyond the Buzzwords
Seth Golden, , Research Reports, 0
Some of the 21st century’s biggest breakthroughs are happening in health care, transforming the way we diagnose, treat and...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00